Advertisement
Legal/Regulatory
Subscribe to Legal/Regulatory

The Lead

Supplement Maker Admits Lying About Ingredients

December 18, 2014 11:03 am | News | Comments

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.. Read more...                                              

Enamine, Sanofi Extend Early Drug Discovery Collaboration

December 18, 2014 9:06 am | News | Comments

Enamine and Sanofi extend partnership for early drug discovery. Read more...   ...

New Generation of Cancer Drugs Granted European Approval

December 18, 2014 8:26 am | by University of Cambridge | News | Comments

A new drug for ovarian cancer has become the first of new class of drugs to be granted approval...

Despite Risks, Benzodiazepine Use Highest in Older People

December 17, 2014 4:50 pm | by NIH | News | Comments

Prescription use of benzodiazepines — a widely used class of sedative and anti-anxiety...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Ohio House to Consider Lethal Injection Drug Bill

December 17, 2014 12:22 pm | News | Comments

The names of companies that provide Ohio with lethal injection drugs would be shielded under a proposal the state House is poised to vote on Wednesday. Read more...                                        

Veloxis Announces Action Against FDA Over Prophylaxis Drug

December 17, 2014 9:54 am | News | Comments

Veloxis Pharmaceuticals announced that it has filed an action in federal district court against the Food and Drug Administration. Read more...                    

House Searches for Ebola in Sierra Leone Capital

December 17, 2014 9:25 am | by Clarence Roy-Macaulay - Associated Press | News | Comments

Surveillance teams fanned out Wednesday in Sierra Leone's capital to search every house for sick people. Read more...                        

Advertisement

14 Charged in Deadly 2012 Meningitis Outbreak

December 17, 2014 9:06 am | by Denise Lavoie - Associated Press | News | Comments

14 former owners or employees of a Massachusetts pharmacy were charged Wednesday in connection with a 2012 meningitis outbreak that killed 64 people. Read more...                 

Hep C: The Fight for a Fair Drug Price

December 16, 2014 2:38 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The price of one pill has placed Gilead Sciences in the middle of a lawsuit. Read more...                             

Judge Halts Alzheimer's Drug Swap Until July

December 16, 2014 10:49 am | by Associated Press | News | Comments

A federal judge on Monday ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug. Read more...                                                  

FDA Approves Drug That Extends Lung Cancer Survival

December 15, 2014 1:37 pm | by University of California, Los Angeles | News | Comments

The FDA approved a new drug to treat non-small-cell lung cancer offering people new hope in fighting the disease. Read more...                       

FDA Approves Drug That Extends Lung Cancer Survival

December 15, 2014 1:36 pm | by University of California, Los Angeles | News | Comments

The FDA approved a new drug to treat non-small-cell lung cancer offering people new hope in fighting the disease. Read more...                       

Advertisement

Anthera Licenses Japan Rights for Blisibimod to Zenyaku

December 15, 2014 11:11 am | News | Comments

Anthera Pharmaceuticals, Inc. announced that Anthera and Zenyaku Kogyo Co., Ltd. of Tokyo, Japan executed an exclusive license agreement for the development and commercialization of subcutaneous blisibimod in Japan and potentially other countries throughout Asia.  Read more...

OPKO, Pfizer Enter Into Global Agreement for hGh

December 15, 2014 10:44 am | News | Comments

OPKO Health, Inc. and Pfizer Inc. announced that they have entered into a worldwide agreement for the development and commercialization of OPKO’s long-acting hGH-CTP for the treatment of growth hormone deficiency (GHD) in adults and children, as well as for the treatment of growth failure in children born small for gestational age (SGA) who fail to show catch-up growth by 2 years of age. Read more...

J&J Collaborates with Janssen,USAID to Expand Access to MDR-TB Compound

December 12, 2014 11:15 am | News | Comments

Johnson & Johnson today announced that its affiliate Janssen Therapeutics, Division of Janssen Products, LP (Janssen), has signed a Memorandum of Understanding (MOU) representing the intention of the Company along with the United States Agency for International Development (USAID) to step up the fight against the health threat of antibiotic-resistant bacteria. Read more...

Abbott Acquires Veropharm for $305M

December 12, 2014 9:56 am | News | Comments

Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer. Read more...                        

Minnesota Board Won't Set Rules on Execution Drugs

December 11, 2014 2:09 pm | by Brian Bakst - Associated Press | News | Comments

Minnesota pharmacy regulators declined Wednesday to set a pioneering policy sought by death-penalty opponents that would explicitly bar the manufacture of lethal drugs for use in executions elsewhere. Read more...        

Advertisement

Epidemics Are Optional

December 11, 2014 11:37 am | by Kalpana Jain, Harvard Divinity School Communications | News | Comments

The large number of deaths from the Ebola virus is primarily due to the lack of sufficient medical care where it’s needed most. Read more...                    

Merck Advancing Breast Cancer Drug to Mid-Stage

December 11, 2014 11:33 am | by Linda A. Johnson - AP Business Writer | News | Comments

Merck said it will start mid-stage patient tests of Keytruda in the first half of 2015. Read more...                           

Gilead Faces Lawsuit Over Hepatitis C Drug Pricing

December 11, 2014 8:49 am | News | Comments

Gilead has been selling a 12-week treatment of Sovaldi in the United States for approximately $84,000, or $1,000 per pill. Read more...                     

Ohio Lawmakers Debate Execution Drugmaker Bill

December 10, 2014 1:01 pm | by Andrew Welsch-Huggins, AP Legal Affairs Writer - Associated Press | News | Comments

Companies providing Ohio with lethal injection drugs would have their names shielded for at least 20 years, under a bill scheduled for a possible vote that lawmakers say is needed to restart executions in the state. Read more...                                  

Merck Committed to Cubist After Patent Loss

December 9, 2014 3:06 pm | by Tom Murphy - AP Business Writer | News | Comments

Shares of both companies tumbled Tuesday morning in the first day of trading. Read more...                             

Report Shows Doctors Prescribing Fewer Opioids for Pain

December 9, 2014 1:06 pm | by John Hopkins School of Public Health | News | Comments

Nine in 10 primary care physicians say that prescription drug abuse is a moderate or big problem in their communities. Read more...                      

Parkinson's Vaccine Being Tested on Patients in Europe

December 9, 2014 9:24 am | News | Comments

This vaccine is one out of a designated pool of promising vaccine candidates. Read more...                             

Trial Launched to Evaluate Amgen and Merck's Melanoma Treatment

December 9, 2014 9:04 am | News | Comments

Amgen announced the initiation of a trial of a new melanoma treatment. Read more...                              

Bad Data Adds Another Problem to Ebola Outbreak

December 8, 2014 2:50 pm | by Maria Cheng and Sarah Dilorenzo - Associated Press | News | Comments

Having accurate numbers about the Ebola outbreak is essential not only to provide a realistic picture of the epidemic, but to determine effective control strategies. Read more...            

Pfizer Expands Rare Disease Research with Gene Therapy Platform

December 8, 2014 12:34 pm | News | Comments

Pfizer announced two strategic decisions to expand the company’s rare disease research and development activities. Read more...                       

Merck Buys Cubist Pharmaceuticals for $8.4B

December 8, 2014 12:27 pm | by Tom Murphy - AP Business Writer | News | Comments

Merck will spend $8.4 billion to buy Cubist Pharmaceuticals. Read more...                                

VIDEO: Drug Development in a Time of Ebola

December 8, 2014 10:04 am | by Ryan Bushey, Associate Editor | Videos | Comments

This video from the Forbes Healthcare Summit focuses on the drug development process during a time of ebola. Watch it here...                       

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading